by Omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) play an important role in human health offering various health benefits like improving cardiovascular health, cognitive function, and metabolic health. EPA and DHA have wide applications in food and beverage, pharmaceuticals, infant formula, and clinical nutrition products. The growing awareness about the numerous health benefits of EPA and DHA is driving their demand in food and beverage products such as bakery and confectionery items, dairy products, breakfast cereal, and snacks enriched with omega-3. Additionally, rising health consciousness among individuals is propelling them towards healthier diets which in turn boosts the demand for omega-3 enriched food items.
The global EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends witnessed in the EPA and DHA market is the growing demand for algae-derived DHA and EPA over fish-oil derived ones. This is because algae-derived DHA and EPA offer benefits like free of mercury content, sustainable, and vegan-friendly. Large suppliers and manufacturers are investing in R&D to produce high-quality algal DHA and EPA at lower production costs to cater to the increasing demand. Additionally, innovative product launches with EPA and DHA in novel applications like infant formula, clinical nutrition, beverages, and supplements are anticipated to drive the market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the EPA and DHA market is moderate as the establishment of manufacturing facilities requires high capital investments and the market is dominated by major players.
Bargaining power of buyers: The bargaining power of buyers in the EPA and DHA market is moderate as buyers have limited options and brands have established brand loyalty.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as the raw materials required are commodities available from numerous sources globally.
Threat of new substitutes: The threat of substitutes is low as EPA and DHA have distinctive health benefits that are difficult to replicate.
Competitive rivalry: The competitive rivalry in the EPA and DHA market is high owing to the presence of numerous global and regional players competing on the basis of product quality, price, innovation, and distribution.
Key Takeaways
The Global EPA And DHA Market Size is expected to witness high growth over the forecast period owing to the growing awareness about the health benefits of omega-3 fatty acids. The global EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031.
Regionally, North America is expected to dominate the market during the forecast period due to the early adoption of dietary supplements and growing health-conscious consumer base in the region.
Europe is also expected to grow significantly in the EPA and DHA market. The increasing consumer inclination towards proactive health management and prevalence of lifestyle diseases are major factors expected to drive the demand for EPA and DHA in Europe.
Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA (Tetra Laval Group), Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group (Tetra Laval Group), Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. The major players are focusing on new product development and strategic collaborations to expand their market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
